Literature DB >> 185547

Glioblastoma multiforme and the meningeal syndrome.

J L Bernat.   

Abstract

Brain tumors rarely may produce acute steile meningitis (the meningeal syndrome) resulting from the spillage of blood, lipid products of tumor necrosis, or malignant cells into the cerebrospinal fluid (CSF). The frequency of the associated meningeal syndrome is a function of tumor type and of the tproximity of tumor necrosis to the ventricles. The meningeal syndromes of lipid-induced chemical inflammation are seen most commonly with epidermoids, craniopharyngiomas, and infarcted pituitary adenomas. I report a patient with the rare association of the meningeal syndrome with glioblastoma multiforme. The lipid irritants of glioblastomas and craniopharyngiomas are similar chemically and can be detected in the CSF. The anti-inflammatory and immunosuppressant properties of steroids provide a rational basis for their efficacy in treatment of the syndrome.

Entities:  

Mesh:

Year:  1976        PMID: 185547     DOI: 10.1212/wnl.26.11.1071

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

Review 1.  Cranial and spinal tumors with meningitic onset.

Authors:  P Lunardi; P Missori
Journal:  Ital J Neurol Sci       Date:  1990-04

2.  Supratentorial meningeal spread from brainstem glioma.

Authors:  E P Vries; M De Visser; D Troost
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

Review 3.  Aggressive treatment with complete remission in primary diffuse leptomeningeal gliomatosis--a case report.

Authors:  P Beauchesne; J Pialat; R Duthel; F G Barral; G Clavreul; T Schmitt; B Laurent
Journal:  J Neurooncol       Date:  1998-04       Impact factor: 4.130

4.  Aseptic meningitis and hydrocephalus after posterior fossa surgery.

Authors:  H H Kaufman; P W Carmel
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

5.  Cerebrospinal metastases in malignant childhood astrocytomas.

Authors:  R S Kandt; S Shinnar; B J D'Souza; H S Singer; M D Wharam; P K Gupta
Journal:  J Neurooncol       Date:  1984       Impact factor: 4.130

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.